A: BPC-157 is not FDA-approved for human therapeutic use and is legally classified as a research compound
En los ltimos aos, el mundo de la medicina ha observado un avance significativo en el tratamiento de la obesidad y el manejo del peso corporal gracias al desarrollo de los anlogos de GLP-1 (a-GLP1 en adelante)
stable at room temperature for approximately 3 weeks Reconstituted BPC-157: Store at 2 to 8C (refrigerator temperature) and use within 4 weeks Protect from light and avoid repeated freeze-thaw cycles Never use the solution if it appears cloudy or contains particles Side Effects Preclinical animal studies have demonstrated a favorable safety profile for BPC-157, with no acute toxicity observed across multiple organ systems, including liver, spleen, lung, kidney, brain, thymus, prostate, and ovaries at doses ranging from 6 g/kg to 20 mg/kg over 6-week periods
GLP-1s reduce appetite significantly, which drives weight loss, but some of that weight loss can come from muscle, not just fat
Nearly two thirds of patients discontinue treatment before reaching the 12-week mark needed for meaningful weight loss
Nature Reviews Molecular Cell Biology, 22 (2), 75-95